Cognitive and behavior therapy in the treatment and prevention of depression

Depression and Anxiety

Volumn 28, Issue 4, 2011, Pages 263-266

  Hollon, Steven D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; COGNITIVE THERAPY; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR DEPRESSION; MEDICAL EDUCATION; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; CLINICAL TRIALS AS TOPIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FOLLOW-UP STUDIES; HUMANS; PSYCHOTHERAPY; RECURRENCE;

EID: 79953763842     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20797     Document Type: Review

References (24)

1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000;157:1-45.
2. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163: 1905-1917. (Pubitemid 44807782)
3. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. J Am Med Assoc 2002;287: 203-209. (Pubitemid 34251945)
4. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Eng J Med 2008;358:252-260.
5. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. J Am Med Assoc 2010;303:47-53.
6. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychol Sci Pub Int 2002;3:39-77.
7. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-982. (Pubitemid 19278225)
8. Elkin I, Gibbons RD, Shea T, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1995;63:841-847.
9. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs. medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409-416. (Pubitemid 40471690)
10. Fournier JC, DeRubeis RJ, Shelton RC, et al. Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. Br J Psychiatry 2008;192: 124-129. (Pubitemid 351269646)
11. Leykin Y, Amsterdam JD, DeRubeis RJ, Gallop R, Shelton RC, Hollon SD. Progressive resistance to selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol 2007;75:267-276. (Pubitemid 47444731)
12. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009;77:775-787.
13. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Arch Gen Psychiatry 2005;62: 417-422. (Pubitemid 40471691)
14. Hollon SD, Stewart MO, Strunk D. Cognitive behavior therapy has enduring effects in the treatment of depression and anxiety. Ann Rev Psychol 2006;57:285-315. (Pubitemid 43237234)
15. Strunk DR, DeRubeis RJ, Chiu AW, et al. Patients' competence in and performance of cognitive therapy skills: relation to the reduction of relapse following treatment for depression. J Consult Clin Psychol 2007;75:523-530. (Pubitemid 47444756)
16. Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC. Sudden gains in cognitive therapy of depression and relapse/recurrence. J Consult Clin Psychol 2007;75:404-408. (Pubitemid 47444744)
17. Strunk DR, Brotman M, DeRubeis RJ, Hollon SD. Therapist competence in cognitive therapy for depression: predicting subsequent symptom change. J Consult Clin Psychol 2010;78: 429-437.
18. Garber J, Clarke GN, Weersing VR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. J Am Med Assoc 2009;301:2215-2224.
19. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006;74:658-670. (Pubitemid 44199118)
20. Coffman S, Martell CR, Dimidjian S, et al. Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? J Consult Clin Psychol 2007;75: 531-541.
21. Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 2008;76:468-477. (Pubitemid 351822347)
22. Driessen E, Cuijpers P, Hollon SD, et al. Does pre-treatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. J Consult Clin Psychol 2010:78;668-680.
23. Strunk DR, Stewart MO, Hollon SD, et al. Can pharmacotherapies be too supportive? A process study of active medication and placebo in the treatment of depression. Psychol Med 2010;40:1379-1387.
24. Tang TZ, DeRubeis RJ, Hollon SD, et al. A placebo-controlled test of the effects of paroxetine and cognitive therapy on personality risk factors in depression. Arch Gen Psychiatry 2009; 66:1322-1330.